The FDA has approved updated prescribing information for Airsupra to include the BATURA study in patients with mild asthma.
ES-SCLC accounts for the majority of small-cell lung cancer diagnoses and is characterized by rapid progression and poor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback